International Edition
Latest News
Health

NEJM March 2026: Volume 394, Issue 11 – Latest Research

Fish Oil Supplement Cuts Heart Attack Risk by 43% for Hemodialysis Patients A recent study published in the New England Journal of Medicine in March 2026 reveals that daily supplementation with n-3 polyunsaturated fatty acids – commonly found…

Fish Oil Supplement Cuts Heart Attack Risk by 43% for Hemodialysis Patients

A recent study published in the New England Journal of Medicine in March 2026 reveals that daily supplementation with n-3 polyunsaturated fatty acids – commonly found in fish oil – significantly reduces the risk of serious cardiovascular events in patients undergoing hemodialysis. The research, conducted by a team of doctors from Canada, Australia, and California, offers a potential breakthrough for a population particularly vulnerable to heart disease.

Cardiovascular Disease and Hemodialysis

Cardiovascular disease is the leading cause of death among patients receiving hemodialysis, a life-sustaining treatment for kidney failure that uses an external machine to filter blood. Despite the high risk, effective preventative therapies have been limited until now. Researchers noted a gap in understanding how to best support cardiovascular wellness in this specific patient group.

The Study Design

The research team analyzed 3.5 years of longitudinal data from 1,228 patients at dialysis locations in Canada, and Australia. Participants were divided into two groups: one receiving a capsule containing corn oil (the placebo group), and the other receiving four grams of n-3 polyunsaturated fatty acids daily (the test group).

Key Findings

The study demonstrated a substantial reduction in serious cardiovascular events among patients taking the fish oil supplement compared to those receiving the placebo. Specifically, the fish oil group experienced:

  • A 45% reduction in cardiac death
  • A 44% reduction in heart attacks
  • A 63% reduction in stroke
  • A 43% reduction in peripheral vascular disease leading to amputation

Implications for Patient Care

These findings suggest that daily supplementation with n-3 fatty acids could be a valuable addition to the care of patients undergoing hemodialysis. The research team concluded that the rate of serious cardiovascular events was lower with fish oil supplementation than with placebo. This offers hope for improving the health and longevity of individuals relying on this critical treatment.

Source

The Healthy

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”